RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Kinnevik
K

Kinnevik portfolio

Kinnevik has 12 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Website: kinnevik.com.
Type: Growth equity.
Portfolio on Recent Funding: 12.
Deals, last 12 months: 1.
Rounds led: 7 of 18.
Capital in their rounds: $1.97B.
Latest deal: Tandem Health · Sep 14, 2026.
About this page

It is a growth equity firm based in Stockholm, SE, founded in 1936. It led 7 of the 18 rounds it joined. Its most recent investment on record is Tandem Health's $100M Series B+ round in September 2026, alongside Visionaries Club, Amino Collective, Northzone and 1 other. By category, its portfolio leans toward Health and bio (7) and Commerce and retail (4). It has co-invested with Felix Capital, General Catalyst and LocalGlobe, most often Felix Capital (6 rounds).

About Kinnevik

Firm type: Growth equity.
Headquarters: Stockholm, SE.
Founded: 1936.
Stages: Series A, Series B, Series C, Growth.
Sectors: AI & Machine Learning, Biotech, Cleantech, Climate Tech, Cloud Computing, Digital Health, Healthtech, Mental Health, SaaS.
Portfolio companies: 43.
Exits: 3.
Rounds led: 18.

What Kinnevik invests in

Kinnevik recent investments

CompanyRoundDateAlongside
TTandem HealthSeries B+ · $100MVisionaries Club, Amino Collective, Northzone +1
NNorySeries B+ · $37M · leadAccel, NAP
PPerkSeries B+ · $200MNoteus Partners, Atomico (lead), General Catalyst +1
EEnvedaSeries B+ · $130M · leadLux Capital, FPV Ventures (lead), The Nature Conservancy +1
HHungry PandaSeries B+ · $55MPerwyn, Mars Growth Capital (lead), Felix Capital +1
EEnvedaSeries B+ · $55MJazz Venture Partners, Level Ventures, True Ventures +5
TTranscarentSeries B+ · $126MMerck Global Health Innovation Fund, Memorial Hermann Health System, Leaps by Bayer +6
PPelagoSeries B+ · $58MAtomico (lead), Octopus Ventures, Y Combinator +2

How Kinnevik invests

StageDealsCapital in rounds
Series B+ 18 100%$1.97B
YearDealsCapital in rounds
2018 1 6%$44M
2019 1 6%$60M
2021 3 17%$390M
2022 3 17%$515M
2023 1 6%$100M
2024 6 33%$528M
2025 2 11%$237M
2026 1 6%$100M

Kinnevik portfolio companies

CompanyRound with KinnevikTotal raisedLatest raise
TTandem Health
Health and bio
Series B+ · $100M$159.5MSep 14, 2026
Series B+
NNory
Health and bio
Series B+ · $37M · lead$62.7MSep 16, 2025
Series B+
PPerk
Fintech
Series B+ · $200M$712.5MJan 27, 2025
Series B+
EEnveda
Health and bio
Series B+ · $130M · lead$714MSep 23, 2026
Series B+
HHungry Panda
Commerce and retail
Series B+ · $55M$205MSep 30, 2024
Series B+
TTranscarent
Health and bio
Series B+ · $126M$384MMay 2, 2024
Series B+
PPelago
Health and bio
Series B+ · $58M$58MApr 26, 2025
Series A
CCharm Industrial
Climate and energy
Series B+ · $100M$100MJun 6, 2023
Series B+
SSolugen
Health and bio
Series B+ · $200M · lead$643.4MMar 17, 2026
Series B+
SSure
Fintech
Series B+ · $100M · lead$110.6MApr 7, 2025
Series B+
AAnterior
Health and bio
backer$60MFeb 12, 2026
Series B+
JJob and Talent
HR and recruiting
backerundisclosedApr 10, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 18 rounds on Recent Funding that name Kinnevik. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Kinnevik, which is a subset of its real portfolio. API: /api/v1/investors/kinnevik (get a free API key). More: the most active VC firms and new venture capital funds.